BioSpace News Archive

Indegene today announced the acquisition of Medical Marketing Economics, LLC (MME).

LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results.

Meridian Bioscience, Inc., a provider of diagnostic testing solutions and life science raw materials, announced its participation in the H. C. Wainwright 23rd Annual Global Investment Conference.

Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced the closing of an underwritten public offering of 5,000,000 shares of common stock of the Company for total gross proceeds to the Company of approximately $15 million.

Emily Greer, a 30-year executive leader for ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital®, and current Chief Administrative Officer, has announced plans to retire on Dec. 31, 2021.

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360® Coronary Orbital Atherectomy System (OAS).

Novavax, Inc. today announced that the U.S. Centers for Disease Control and Prevention (CDC) has provided updated guidance for those who have been vaccinated as part of a clinical trial in the U.S.

Adesis, Inc. today announced that Linda Choi MacDonald has joined the company as Chief Operating Officer.

Talis Biomedical Corporation today announced that effective immediately Brian Coe has stepped down as President, CEO and Director and will continue to work with the company as an advisor. The company also announced that Kim Popovits has been appointed as interim CEO

Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today reported financial results for its second quarter ended June 30, 2021 and provided a corporate update.